(Q38386346)

2 September 2017

1 reference

title

Breast cancer under age 40: a different approach (English)

1 reference

2 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Berta Sousa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

D Ribnikar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

D Pinto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

A C Pinto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

E Gomes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

E C Moser

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

M J Cardoso

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

F Cardoso

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

1 April 2015

1 reference

Current Treatment Options in Oncology

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25796377%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11864-015-0334-8

7 June 2020

exact match

0 references

cites work

Management of breast cancer in very young women

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

First international consensus guidelines for breast cancer in young women (BCY1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Variability in measuring the Ki-67 labeling index in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Occurrence of breast cancer subtypes in adolescent and young adult women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Rare breast tumors: Review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Age-specific differences in oncogenic pathway deregulation seen in human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Understanding the biology of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Breast cancer before age 40 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Patient and tumor characteristics associated with increased mortality in young women (< or =40 years) with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Breast cancer in young women: poor survival despite intensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

1st International consensus guidelines for advanced breast cancer (ABC 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Body image in recently diagnosed young women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Patient age and preoperative breast MRI in women with breast cancer: biopsy and surgical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Preoperative genetic testing affects surgical decision making in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Extended indications for nipple-sparing mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Analysis of local and regional recurrences in breast cancer after conservative surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Breast cancer subtypes and the risk of local and regional relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

A changing perspective: improving access to fertility preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

The management of early-stage and metastatic triple-negative breast cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Adjuvant ovarian suppression in premenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Breast-cancer adjuvant therapy with zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Inflammatory breast cancer: the disease, the biology, the treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Triple-negative breast cancer: role of specific chemotherapy agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Screening for recurrences in patients treated with breast-conserving surgery: is there a role for MRI?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Impact of US surveillance on detection of clinically occult locoregional recurrence after mastectomy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Ovarian function preservation with GnRH agonist in young breast cancer patients: does it impede the effect of adjuvant chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Delayed childbearing and the outcome of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

'Informed and uninformed decision making'--women's reasoning, experiences and perceptions with regard to advanced maternal age and delayed childbearing: a meta-synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Oncofertility: an emerging discipline in obstetrics and gynecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Fertility after breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Options on fertility preservation in female cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Oncofertility in Canada: the impact of cancer on fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Caring for the breast cancer survivor's health and well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Pregnancy after Breast Cancer: Myths and Facts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

Long-term cosmetic changes after breast-conserving treatment of patients with stage I–II breast cancer and included in the EORTC ‘boost versus no boost’ trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-015-0334-8

The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast

21 January 2018

1 reference

12 December 2020

Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy

1 reference

12 December 2020

Breast cancer, pregnancy, and breastfeeding.

1 reference

12 December 2020

Hormonal therapies in young breast cancer patients: when, what and for how long?

1 reference

12 December 2020

Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer

1 reference

12 December 2020

Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study

1 reference

12 December 2020

Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma

1 reference

12 December 2020

The influence of young age on outcome in early stage breast cancer

1 reference

12 December 2020

Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients

1 reference

12 December 2020

Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury

1 reference

12 December 2020

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer

1 reference

12 December 2020

Age and prognosis in premenopausal breast cancer

1 reference

12 December 2020

Third-party reproduction and adoption in cancer patients

1 reference

12 December 2020

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials

1 reference

12 December 2020

Bisphosphonates in the adjuvant treatment of young women with breast cancer: the estrogen rich is a poor candidate!

1 reference

12 December 2020

Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial

1 reference

12 December 2020

Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy

1 reference

12 December 2020

Commentary on "aTTom": long-term effects of continuing adjuvant Tamoxifen to 10 years.

1 reference

12 December 2020

Is mastectomy superior to breast-conserving treatment for young women?

1 reference

12 December 2020